Orthopedics. 2011; 34(8): e382-8. doi: 10.3928/01477447-20110627-06.
9. Stolzing A, Jones E, McGonagle D, Scutt A. Age-related changes in
human bone marrow-derived mesenchymal stem cells: consequences for cell
therapies.
Mech
Ageing
Dev.
2008;
129(3):
163-73.
doi:
10.1016/j.mad.2007.12.002.
10. Riordan NH, Ichim TE, Min WP, et al. Non-expanded adipose stromal
vascular fraction cell therapy for multiple sclerosis. J Transl Med. 2009; 7: 29.
doi: 10.1186/1479-5876-7-29.
11. Rodriguez JP, Murphy MP, Hong S, et al. Autologous stromal vascular
fraction therapy for rheumatoid arthritis: rationale and clinical safety. Int Arch
Med. 2012; 5: 5. doi: 10.1186/1755-7682-5-5.
12. Ichim TE, Harman RJ, Min WP, et al. Autologous stromal vascular
fraction cells: a tool for facilitating tolerance in rheumatic disease. Cell Immunol.
2010; 264(1): 7-17. doi: 10.1016/j. cellimm.2010.04.002.
13. Makary MA and Daniel M. Medical error—the third leading cause of
death in the US. BMJ. 2016; 353: i2139. doi: 10.1136/bmj.i2139.
14. O’Donoghue K, Chan J, de la Fuente J, et al. Microchimerism in female
bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in
pregnancy. Lancet. 2004; 364(9429): 179-82.
15. Johnson, KL, Samura O, Nelson JL, McDonnel M d WM, Bianchi DW.
Significant fetal cell microchimerism in a nontransfused woman with hepatitis C:
Evidence of long-term survival and expansion. Hepatology. 2002 Nov; 36(5):
1295-7.
16. Khosrotehrani K and Bianchi DW. Multi-lineage potential of fetal cells
in maternal tissue: a legacy in reverse. J Cell Sci. 2005 15; 118(Pt 8): 1559-63.
17. Turco AE, Bambara LM. Pregnancy, microchimerism and
autoimmunity: an update. Lupus. 2004; 13(9): 659-60.
18. Guthrie KA, Dugowson CE, Voigt LF, Koepsell TD, Nelson JL. Does
pregnancy provide vaccine-like protection against rheumatoid arthritis? Arthritis
Rheum. 2010; 62(7): 1842-8. doi: 10.1002/ art.27459.
